Decheng Capital Management III (Cayman)’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$1.15M Hold
36,171
0.38% 23
2023
Q2
$2.98M Hold
36,171
0.93% 19
2023
Q1
$3.72M Hold
36,171
1.5% 15
2022
Q4
$5.3M Hold
36,171
1.98% 14
2022
Q3
$6.11M Hold
36,171
2.22% 13
2022
Q2
$4.18M Hold
36,171
1.58% 16
2022
Q1
$3.61M Buy
+36,171
New +$3.61M 1.11% 17